Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Lane

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Blood|May 3, 2002
Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and functionGabriella Kunz, Ann-Kristin Ohlin, Antonella Adami, et al.
Blood|July 1, 2011
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factorJames T B Crawley, Rens de Groot, Yaozu Xiang, et al.
Blood|March 15, 2014
Vessel wall BAMBI contributes to hemostasis and thrombus stabilityIsabelle I Salles-Crawley, James H Monkman, Josefin Ahnström, et al.
Blood|December 25, 2009
An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWFWouter Pos, James T B Crawley, Rob Fijnheer, et al.
Blood|April 1, 2010
The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain functionBrenda M Luken, Luke Y N Winn, Jonas Emsley, et al.
Blood|May 12, 2005
Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysisJames S O'Donnell, Thomas A J McKinnon, James T B Crawley, et al.
The Journal of Biological Chemistry|July 27, 2006
Multifunctional specificity of the protein C/activated protein C Gla domainRoger J S Preston, Eva Ajzner, Cristina Razzari, et al.
Blood|September 28, 2002
Protein S Gla-domain mutations causing impaired Ca(2+)-induced phospholipid binding and severe functional protein S deficiencySuely M Rezende, David A Lane, Blandine Mille-Baker, et al.
Blood|November 3, 2007
N-linked glycosylation of VWF modulates its interaction with ADAMTS13Thomas A J McKinnon, Alain C K Chion, Alexander J Millington, et al.
The Journal of Biological Chemistry|February 20, 2003
Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosisSrikumar M Raja, Neetu Chhablani, Richard Swanson, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Blood|May 3, 2002
Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and functionGabriella Kunz, Ann-Kristin Ohlin, Antonella Adami, et al.
Blood|July 1, 2011
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factorJames T B Crawley, Rens de Groot, Yaozu Xiang, et al.
Blood|March 15, 2014
Vessel wall BAMBI contributes to hemostasis and thrombus stabilityIsabelle I Salles-Crawley, James H Monkman, Josefin Ahnström, et al.
Blood|December 25, 2009
An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWFWouter Pos, James T B Crawley, Rob Fijnheer, et al.
Blood|April 1, 2010
The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain functionBrenda M Luken, Luke Y N Winn, Jonas Emsley, et al.
Blood|May 12, 2005
Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysisJames S O'Donnell, Thomas A J McKinnon, James T B Crawley, et al.
The Journal of Biological Chemistry|July 27, 2006
Multifunctional specificity of the protein C/activated protein C Gla domainRoger J S Preston, Eva Ajzner, Cristina Razzari, et al.
Blood|September 28, 2002
Protein S Gla-domain mutations causing impaired Ca(2+)-induced phospholipid binding and severe functional protein S deficiencySuely M Rezende, David A Lane, Blandine Mille-Baker, et al.
Blood|November 3, 2007
N-linked glycosylation of VWF modulates its interaction with ADAMTS13Thomas A J McKinnon, Alain C K Chion, Alexander J Millington, et al.
The Journal of Biological Chemistry|February 20, 2003
Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosisSrikumar M Raja, Neetu Chhablani, Richard Swanson, et al.
Pageof 7